Psilera Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $8.8M

  • Investors
  • 12

Psilera General Information

Description

Developer of psychedelic-based drugs designed for neurological therapeutics. The company's proprietary neuromodulator pipeline is developed by repurposing psychoactive natural products as building blocks for next-generation therapies to improve mental health, enabling clinicians to treat cognitive, mood, and substance use disorders.

Contact Information

Website
www.psilera.com
Formerly Known As
Psilera Bioscience
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3201 West Hillsborough Avenue
  • Suite 151868
  • Tampa, FL 33614
  • United States
+1 (727)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 3201 West Hillsborough Avenue
  • Suite 151868
  • Tampa, FL 33614
  • United States
+1 (727)

Psilera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Psilera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-May-2026 $8.8M Completed Pre-Clinical Trials
6. Grant 15-Sep-2025 Completed Pre-Clinical Trials
5. Grant 05-Sep-2024 Completed Pre-Clinical Trials
4. Seed Round 30-Sep-2023 Completed Startup
3. Seed Round 01-Jul-2021 Completed Startup
2. Accelerator/Incubator 09-Jul-2020 $50K $240K Completed Startup
1. Capitalization 01-Jan-2020 $190K $190K Completed Startup
To view Psilera’s complete valuation and funding history, request access »

Psilera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Psilera’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Psilera Patents

Psilera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024275806-A1 Formulations containing tryptamine derivatives and uses thereof Pending 24-May-2023
EP-4720039-A2 Formulations containing tryptamine derivatives and uses thereof Pending 24-May-2023
US-20260306453-A1 Formulations containing tryptamine derivatives and uses thereof Pending 24-May-2023
WO-2024243488-A2 Formulations containing tryptamine derivatives and uses thereof Inactive 24-May-2023
WO-2024243488-A3 Formulations containing tryptamine derivatives and uses thereof Inactive 24-May-2023 A61K31/4045
To view Psilera’s complete patent history, request access »

Psilera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Psilera Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
U.S. Department of Health and Human Services Government
University of South Florida University
Bonaventure Equity Venture Capital Minority
Frühstarter Ventures Angel Group Minority
Mystic Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Psilera FAQs

  • When was Psilera founded?

    Psilera was founded in 2019.

  • Where is Psilera headquartered?

    Psilera is headquartered in Tampa, FL.

  • What is the size of Psilera?

    Psilera has 10 total employees.

  • What industry is Psilera in?

    Psilera’s primary industry is Drug Discovery.

  • Is Psilera a private or public company?

    Psilera is a Private company.

  • What is Psilera’s current revenue?

    The current revenue for Psilera is .

  • How much funding has Psilera raised over time?

    Psilera has raised $16.2M.

  • Who are Psilera’s investors?

    U.S. Department of Health and Human Services, University of South Florida, Bonaventure Equity, Frühstarter Ventures, and Mystic Ventures are 5 of 12 investors who have invested in Psilera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process